Geneos Wealth Management Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1764754
ENGLEWOOD, CO
Position in REGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$645,154
+$12,221 QoQ
Shares Held
835
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Geneos Wealth Management Inc. holds $2,712,041 across 32 Biotechnology names. REGN ranks #3 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
12,399 | $801,347 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
240,927 | $672,186 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
835 | $645,154 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
48,600 | $149,202 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
2,169 | $72,054 | |
| 6 | INSM |
INSMED Inc
|
414 | $67,697 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $45,100 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
5,754 | $44,133 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $645,154 | 835 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $632,933 | 820 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $495,922 | 882 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $409,500 | 780 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $480,112 | 757 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $491,507 | 690 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $722,201 | 687 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $847,130 | 806 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $814,266 | 846 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $758,842 | 864 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $745,601 | 906 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $724,288 | 1,008 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $852,071 | 1,037 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $783,538 | 1,086 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $773,601 | 1,123 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $659,109 | 1,115 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $822,040 | 1,177 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $762,244 | 1,207 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $744,371 | 1,230 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $793,685 | 1,421 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $737,625 | 1,559 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $778,290 | 1,611 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $193,683 | 346 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $212,664 | 341 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $262,211 | 537 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||